| Literature DB >> 28674064 |
Yannick Hoyos-Mallecot1,2,3, Thierry Naas4,2,3,5, Rémy A Bonnin1,2,3,5, Rafael Patino5, Philippe Glaser5, Nicolas Fortineau1,2,3,5, Laurent Dortet1,2,3,5.
Abstract
OXA-244 is a single-point-mutant derivative of OXA-48 displaying reduced carbapenemase activity. Here, we report the microbiological features of seven OXA-244-producing Escherichia coli isolates. Only one isolate grew on ChromID Carba Smart medium (bioMérieux), but six of the seven isolates grew on ChromID extended-spectrum-β-lactamase (ESBL) medium (bioMérieux), as they coproduced an ESBL and/or a plasmid-encoded cephalosporinase. The production of a carbapenemase was detected in 57.1%, 71.4%, 71.4%, and 100% of the E. coli isolates using the Carba NP test, the Rapidec Carba NP test (bioMérieux), a matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) hydrolysis assay (Bruker), and the OXA-48 K-SeT assay (Coris BioConcept), respectively. Our results indicate that OXA-244-producing E. coli isolates are difficult to detect, which may lead to their silent spread.Entities:
Keywords: OXA-244; OXA-48-like; carbapenemase activity; detection; screening; tests
Mesh:
Substances:
Year: 2017 PMID: 28674064 PMCID: PMC5571363 DOI: 10.1128/AAC.00818-17
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191